重新发现氧:一种金属化剂,可以弥合感染和癌症
Praveen Papareddy1, Sophie R M Mielke2, Marlowe Graham3
1Department of Laboratory Medicine, Lund University, Biomedical Center, Lund, Sweden.
Drug discovery today
|June 28, 2025
概括
抗微生物药物尼特洛克因其广泛的活性而显示出治疗感染和癌症的前景. 然而,其临床使用受到药理动力学不佳的阻碍,需要进一步研究有效的治疗策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 抗菌研究 抗菌研究
- 在瘤学瘤学.
背景情况:
- 尼트로克索林是一种已确定的抗微生物剂.
- 它表现出广泛的活性,包括生物膜破坏和金属化.
- 在传染病和瘤学中出现了重新利用的潜力.
研究的目的:
- 审查最近在尼特洛克索林的作用机制的进展.
- 探索其跨王国活动和抗癌效应.
- 讨论临床翻译的挑战和机会.
主要方法:
- 最近的临床前和临床研究的文献综述.
- 对尼特洛克索林的药理动力学特性进行分析.
- 在传染病和瘤疾病模型中评估其疗效.
主要成果:
- 在临床前研究中,氧显示出显著的抗微生物和抗癌潜力.
- 它的金属化和生物膜破坏性质是其活动的关键.
- 药物动力学限制 (快速分泌,半衰期短) 阻碍了系统应用.
结论:
- 尼托克索林是药物重用在传染病和瘤学中的有希望的候选者.
- 克服药物动力学和监管方面的挑战对于临床转化至关重要.
- 需要进一步的研究来优化基于尼特素的治疗策略.
更多相关视频
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
14.1K
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
6.1K
相关概念视频
Metal-Ligand Bonds
21.5K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
21.5K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Electron Transport Chain: Complex I and II
15.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Complexation Equilibria: The Chelate Effect
681
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
681
